These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8173129)

  • 1. Effect of preparation method and storage on rifampin concentration in suspensions.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1994 Feb; 28(2):182-5. PubMed ID: 8173129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of rifampin in two suspensions at room temperature.
    Nahata MC; Morosco RS; Hipple TF
    J Clin Pharm Ther; 1994 Aug; 19(4):263-5. PubMed ID: 7989407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of 1% rifampin suspensions prepared in five syrups.
    Krukenberg CC; Mischler PG; Massad EN; Moore LA; Chandler AD
    Am J Hosp Pharm; 1986 Sep; 43(9):2225-8. PubMed ID: 3766578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1993 Oct; 27(10):1198-9. PubMed ID: 8251687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of cisapride in a liquid dosage form at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1995 Feb; 29(2):125-6. PubMed ID: 7756708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of two stable oral suspensions for gabapentin.
    Nahata MC
    Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of an extemporaneously prepared thalidomide suspension.
    Kraft S; Johnson CE; Tyler RP
    Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of extemporaneously compounded spironolactone suspensions.
    Mathur LK; Wickman A
    Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of extemporaneous suspensions of carbamazepine.
    Burckart GJ; Hammond RW; Akers MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1929-31. PubMed ID: 7325176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures.
    Nahata MC
    Int J Pharm Compd; 2016; 20(2):164-6. PubMed ID: 27323428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of sotalol in two liquid formulations at two temperatures.
    Nahata MC; Morosco RS
    Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.